Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fuke Qianjin Capsule vs Doxycycline in PID
NCT04723069Phase 2Completed
- Sponsor
- University of Karachi
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Fuke Qianjin in pelvic inflammatory disease (PID), sponsored by University of Karachi. Started Sep 2021; status: completed.
02
Drugs
Fuke Qianjin
03
Conditions
pelvic inflammatory disease (PID)
Beyond the preview
Go deeper on NCT04723069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04723069.